Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Loncar Cancer Immunotherapy ETF (CNCR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Exchange Traded Concepts
  • Assets Under Management 44,280,000
  • Market Capitalization, $K 44,280
  • Shares Outstanding, K 2,000
  • 36-Month Beta 1.97
  • Price/Book 4.05
  • Price/Earnings ttm 14.87
  • Annual Dividend & Yield 0.35 (1.58%)
  • Most Recent Dividend 0.350 on 12/28/17
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.78 +10.96%
on 01/24/19
22.30 -1.58%
on 02/19/19
+1.11 (+5.33%)
since 01/18/19
3-Month
16.87 +30.09%
on 12/24/18
22.30 -1.58%
on 02/19/19
+1.82 (+9.03%)
since 11/20/18
52-Week
16.87 +30.09%
on 12/24/18
32.32 -32.09%
on 03/13/18
-6.60 (-23.13%)
since 02/20/18

Most Recent Stories

More News
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 25.89 (-0.91%)
CNCR : 21.95 (-0.78%)
IBB : 111.10 (-0.27%)
PSCH : 123.24 (+0.54%)
XBI : 85.30 (-0.40%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 25.89 (-0.91%)
CNCR : 21.95 (-0.78%)
IBB : 111.10 (-0.27%)
PSCH : 123.24 (+0.54%)
XBI : 85.30 (-0.40%)
ETFs from Best & Worst Zones of Q1

American equities are on track for the worst quarter since 2015.

SGG : 46.65 (+0.95%)
SCIN : 12.77 (+0.91%)
CNCR : 21.95 (-0.78%)
VMAX : 18.53 (+0.52%)
NIB : 26.25 (-1.46%)
XES : 12.01 (+1.87%)
Top and Flop Sectors of Q1 and Their Wining & Losing Stocks

Inside the top and flop sectors of Q1 and their related winning and losing Stocks.

PPA : 59.52 (+0.51%)
PQ : 0.58 (+3.76%)
CNCR : 21.95 (-0.78%)
PFNX : 3.95 (-4.36%)
CL : 66.51 (-0.31%)
HEI : 92.79 (+0.32%)
USO : 11.93 (+1.27%)
XLE : 66.60 (+0.42%)
PNQI : 129.80 (-0.38%)
VNQ : 84.54 (-0.62%)
ACMR : 11.50 (+15.35%)
WAIR : 8.20 (unch)
GERN : 1.48 (-5.13%)
XLP : 54.53 (-0.18%)
OAKS : 3.44 (+1.18%)
ETFs from Best & Worst Zones of Q1

American equities are on track for the worst quarter since 2015.

SGG : 46.65 (+0.95%)
SCIN : 12.77 (+0.91%)
CNCR : 21.95 (-0.78%)
VMAX : 18.53 (+0.52%)
NIB : 26.25 (-1.46%)
XES : 12.01 (+1.87%)
3 Sector ETFs That Gained Double-Digits in Q1

We have highlighted three sectors ETFs that have have easily survived the market turbulence in the first quarter, gaining in double-digits.

CNCR : 21.95 (-0.78%)
XWEB : 89.52 (-0.28%)
FB : 162.56 (+0.17%)
IBUY : 47.82 (+0.04%)
3 Sector ETFs That Gained Double-Digits in Q1

We have highlighted three sectors ETFs that have have easily survived the market turbulence in the first quarter, gaining in double-digits.

CNCR : 21.95 (-0.78%)
XWEB : 89.52 (-0.28%)
FB : 162.56 (+0.17%)
IBUY : 47.82 (+0.04%)
Here's an ETF to Invest in Immunotherapy--the Game Changing Cancer Treatment

CNCR ETF is up about 30% this year; here is what investors need to know about immunotherapy and the ETF (CNCR, IBB).

CNCR : 21.95 (-0.78%)
IBB : 111.10 (-0.27%)
3 ETF Areas Up At Least 15% This Year

The S&P 500 may offer paltry returns so far this year but these ETF areas remained strong.

FDN : 136.40 (-0.53%)
BBC : 25.89 (-0.91%)
PNQI : 129.80 (-0.38%)
CNCR : 21.95 (-0.78%)
XWEB : 89.52 (-0.28%)
NIB : 26.25 (-1.46%)
DIA : 259.50 (+0.27%)
SPY : 278.41 (+0.20%)
3 ETF Areas Up At Least 15% This Year

The S&P 500 may offer paltry returns so far this year but these ETF areas remained strong.

FDN : 136.40 (-0.53%)
BBC : 25.89 (-0.91%)
PNQI : 129.80 (-0.38%)
CNCR : 21.95 (-0.78%)
XWEB : 89.52 (-0.28%)
NIB : 26.25 (-1.46%)
DIA : 259.50 (+0.27%)
SPY : 278.41 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade CNCR with:

Fund Summary

The Loncar Cancer Immunotherapy ETF seeks investment results that correspond generally to the price and yield per for mance, before fees and expenses, of the Loncar Cancer Immunotherapy Index.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 22.25
1st Resistance Point 22.10
Last Price 21.95
1st Support Level 21.82
2nd Support Level 21.70

See More

52-Week High 32.32
Fibonacci 61.8% 26.42
Fibonacci 50% 24.60
Fibonacci 38.2% 22.77
Last Price 21.95
52-Week Low 16.87

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar